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Abstract—This paper presents a novel approach based on 
the analysis of genetic variants from publicly available genetic 
profiles and the manually curated database, the National 
Human Genome Research Institute Catalog. Using data science 
techniques, genetic variants are identified in the collected 
participant profiles then indexed as risk variants in the 
National Human Genome Research Institute Catalog. Indexed 
genetic variants or Single Nucleotide Polymorphisms are used 
as inputs in various machine learning algorithms for the 
prediction of obesity. Body mass index status of participants is 
divided into two classes, Normal Class and Risk Class. 
Dimensionality reduction tasks are performed to generate a set 
of principal variables - 13 SNPs - for the application of various 
machine learning methods. The models are evaluated using 
receiver operator characteristic curves and the area under the 
curve. Machine learning techniques including gradient 
boosting, generalized linear model, classification and 
regression trees, K-nearest neighbours, support vector 
machines, random forest and multilayer neural network are 
comparatively assessed in terms of their ability to identify the 
most important factors among the initial 6622 variables 
describing genetic variants, age and gender, to classify a 
subject into one of the body mass index related classes defined 
in this study. Our simulation results indicated that support 
vector machine generated high accuracy value of 90.5%. 
Keywords—Data Science; Feature Selection; Genetics; 
Machine Learning; Obesity; Receiver Operating Charasteristic 
Curve; Single Nucleotide Polymorphisms 
I. INTRODUCTION 
The availability and evolution of high-throughput 
genomics has improved biomedical research and moved 
biologist into the big data domain [1-2]. This has enabled 
researchers to uncover genetic variations associated with the 
risk of diseases in a more accurate and reliable way. 
Researchers of this discipline are dealing with enormous data 
sets, encountering challenges with handling, processing and 
moving information that were once the domain of other areas 
of research such as astronomy [3]. However, this rises 
another issue, the extraction of useful knowledge and quality 
interpretation of the data, which could be translated into 
valuable information for doctors and patients [4]. The last 
one, is one of the most important challenges in 
bioinformatics [2], [5]. 
Genome-wide association studies (GWAS) were aimed at 
revealing variants at genomic loci that are associated with 
complex traits in the population. In these studies, a large 
number of genetic variants or Single Nucleotide 
Polymorphisms (SNPs) are tested for association with the 
trait of interest or common diseases, such as obesity, diabetes 
or coronary artery disease among others [6]–[9]. 
Associations between the investigated trait and a SNP are 
termed genome-wide significant. Currently, associations of 
common variants should reach P-Values threshold levels of P 
≤ 5 × 10-8 to be considered significant [10-11]. As the price 
of genome-wide genotyping has dropped, the number of 
studies utilizing GWAS has increased dramatically [12-16]. 
Numerous genetic variants that reached genome-wide 
significant levels in GWAS has been gathered in databases. 
An example of this type of database is the National Human 
Genome Research Institute (NHGRI) Catalog. This is a 
manually curated and publicly available database of SNP-
trait association data, discovered via genetic association 
studies and aimed at finding variants correlated with disease 
risk [17]. The importance of GWAS is advancing scientific 
understanding of disease mechanisms and providing starting 
points and potential opportunities for researchers to improve 
the development of medical treatments or preventing 
therapies [18], [19]. 
There is growing evidence that genetic variation plays an 
important role in determining individual susceptibility to 
complex disease traits. Complex diseases such as obesity 
require a greater implication of the scientific community to 
help counteract this global phenomenon [20]. Currently, 
obesity is considered a worldwide epidemic [21-23]. It is 
associated with multiple conditions, including Type 2 
Diabetes (T2D), cardiovascular disease and certain types of 
cancer [24], [25], making obesity as one of the largest global 
health problems. Several studies have been conducted with 
the aim of studying obesity aetiology [26]. The advance of 
GWAS has successfully identified multiple polymorphisms 
associated with the risk of obesity and higher body mass 
index (BMI). Common variations such as those in the fat 
mass and obesity-associated (FTO) and melanocortin 4 
receptor (MC4R) genes have been associated with obesity 
and BMI [27-28]. These genetic variants associated with 
obesity have been manually collected in existing databases 
such as the NHGRI Catalog [17] or the Genome-wide 
Association Studies database (GWASdb), which includes 
less significant genetic variants in addition to genome-wide 
significant ones [29]. The large volume of SNPs data 
motivates the use of data mining and pattern recognition 
techniques in disease risk prediction and classification [30].  
This paper introduces a genetic profile predictive study 
using machine learning algorithms, in which SNP arrays for 
a set of subjects are used to predict future risk of developing 
complex diseases such as obesity, based on BMI status and 
SNP profile. In addition, feature selection algorithms are 
used to find a set of SNPs relevant to the prediction. 
Consequently, we have developed a methodology which 
includes: publicly available genetic profiles data collection, 
data processing - data cleaning, exploratory data analysis and 
NHGRI Catalog indexation and feature selection. Various 
machine learning models are used for the prediction of 
obesity.   
A deeper understanding of the biology of genomes is 
necessary in order to decipher, interpret, and optimize the 
clinical utility of the variation in the human genome.  
The remainder of this paper is organised as follows. 
Section II reviews the potential application of using artificial 
intelligence in obesity prediction. Section III introduces the 
database utilised as well as the steps necessary to identify the 
genetic variants of interest. In addition, details about feature 
selection and machine learning model comparison adopted 
are presented. The results are reported in Section IV while 
the findings are discussed in Section V. In Section VI the 
paper is concluded.  
II. BACKGROUND 
Prevention and management of obesity in humans is a 
complex and challenging task. This condition has a complex 
aetiology, produced by the combined action of interactions 
between genes, environmental factors and behaviour [31]. 
Literature survey indicates that in industrialized countries, 
between 60% and 70% of the variation in obesity-related 
phenotypes corresponds to hereditary factors [32]. 
Consequently, the genetic components that affect the 
susceptibility of obesity are becoming important elements in 
determining an individual's risk for this disease [8]. 
Nonetheless, the translation of these advances in obesity 
therapies has proven to be a complicated task [26].  
To date, numerous studies using SNPs discovered in 
GWAS for predicting complex diseases have been conducted 
[33-35]. Dominique et al [36] built several multi locust 
genetic risk indicators for obesity. Genetic risk scores (GRS) 
were designed from sets of SNPs identified as genome-wide 
significant in their corresponding studies. The authors 
discussed the effects of cumulative genetic risk on body-
mass phenotypes in white and black young adults. Young 
black and white adults with high genetic risk gained more 
weight and were more likely to become obese as compared 
to those with a lower genetic risk. However, associations in 
the black samples were smaller in magnitude and not 
statistically significant. 
In a comparable study, Hung et al [37] investigated the 
effect of GRS combining multiple BMI risk variants for the 
prediction of obesity in patients with Major Depressive 
Disorder (MDD). The individual risk of each SNP provides a 
modest and limited effect in the prediction of obesity. Hence, 
the authors developed GRS based on 32 well-defined 
common SNPs, to investigate the association of these GRS 
with BMI and help predicting obesity. Linear and logistic 
regression models were utilised to predict BMI and to 
examine the relationship between GRS and obesity, in 
addition to age, sex, ancestry and depression status. The 
results showed that the combination of non-genetic risk 
factors, GRS and depression, produced results close to the 
conventional threshold for clinical use and enhanced 
prediction of obesity. Furthermore, the results suggest that 
GRS may better predict obesity in depressed patients than in 
healthy controls. 
Some studies have used various mechanisms to compare 
the predictive ability against diseases using solely genetic 
variants as features. Uhmn et al [34] applied various machine 
learning techniques including support vector machine 
(SVM), decision tree, decision rule and k-nearest neighbour 
algorithm (K-NN), to predict susceptibility to chronic 
hepatitis using SNPs data. Using a number of SNPs selected 
from possible candidate genes which may cause hepatitis, the 
authors applied a feature selection approach that involved 
several models, to select a smaller subset of SNPs as features 
for classification. Subsequently, a number of machine 
learning techniques were assessed as a tool to diagnose 
chronic hepatitis. The results suggested that decision rule 
with backward elimination and backward elimination with 
backtracking provided the highest accuracy for chronic 
hepatitis [34]. However, the highest score for sensitivity and 
specificity was achieved by decision rule with backward 
elimination and decision tree with backward elimination, 
respectively. Decision tree and rule based system provided 
potential for the diagnosis of chronic hepatitis. 
Genetically based risk assessment is still in its infancy in 
which known variants are not decisive when explaining the 
risk of disease occurrence as predictors in clinical 
environments [38]. The findings presented in the following 
sections of this paper, will help the development of new 
strategies to mitigate the effects of obesity in the global 
population. 
III. MATERIALS AND METHODS 
This section presents the genetic data used in our 
predictions, the pre-processing steps and feature selection 
approaches to identify the most significant SNPs for the 
detection of obesity. Seven machine learning algorithms are 
comparatively used for the prediction and their performances 
are evaluated using the Area Under the Curve (AUC), 
sensitivity and specificity.   
Our solution is based on identifying risk variants present 
in participants of Direct to Consumer Genetic Testing 
(DTCGT) services whose genetic profiles are extracted from 
the Personal Genome Project (PGP) using web scraping 
techniques.  Indexation of SNPs identified as risk in the 
NHGRI Catalog and participant's genetic profiles from the 
PGP Catalog is performed - taking into account information 
extracted from the risk.allele and genotype fields and from 
the NHGRI Catalog and participant's genetic profiles. These 
identified SNPs and their corresponding diseases or traits are 
utilised as features. The results indicated that the number of 
features (variables) obtained, exceeded the number of 
participants (observations) which poses a dimensionality 
problem. Thus, random forest was used for features 
reduction [39-40], [51]. Furthermore, a set of 8 SNPs 
determined in our experiments as possible candidates for the 
prediction is also considered. A total of 13 SNPs associated 
with obesity and T2D related traits, and prostate cancer are 
used as inputs for our prediction. Seven machine learning 
models simulated for the prediction of obesity are used, 
including: gradient boosting [42], generalised linear model 
[43], classification trees [44], k-nearest neighbours (KNN) 
[45], support vector machine (SVM) [46], random forest 
(RF) [47] and multilayer perceptron (MLP)  neural network 
[48] trained using backpropagation. 
Statistical computing and graphics were performed using 
the software environment R [49].  The Caret Package [50] 
was used for the development of the machine learning model 
testing, while Boruta package [39-40] was used for feature 
selection. 
A. Identification of Informative Genetic Variants 
In this paper, we compare 164 genetic profiles of 
DTCGT users participating in PGP with GWAS results 
indexed in the NHGRI Catalog. The participant profiles 
contain SNPs and associated variables which include rsid 
(SNP ID), chromosome, position, and genotype. We focus 
on identifying the frequency of the variants of interest - 
identified as risk alleles - in the 164 examined profiles and if 
they are indexed in the NHGRI Catalog. This mapping 
allows us to link SNPs in our samples with risk alleles 
indexed in the NHGRI Catalog [51]. Hence, this process 
resulted in a reduced set of SNPs per participants, 
constructed by previously identified risk SNPs according to 
NHGRI Catalog. 
We examined the NHGRI catalog for the identification of 
risk variants present in the participant’s genetic profiles. The 
SNPs and genotype listed in the participant’s profiles were 
linked with SNPs and risk alleles reported in the Catalog - 
using metadata from the NHGRI Catalog (“ebicat37”).  
This search process for risk variants in the samples 
generated a data frame with 6620 variables (SNPs) that have 
been associated with numerous conditions, including obesity 
related ones. Therefore, these risk genetic variants are 
considered as possible candidate features for the 
classification analysis. Since the number of variables is 
considerably larger than the number of observations, 
dimensionality reduction is performed using feature selection 
techniques. 
B. Feature Selection 
Obesity relates to the total fat mass of an individual and 
is conveniently measured by direct fat methods using, for 
example, imaging techniques [8]. Surrogate measurements 
such us BMI or waist circumference are commonly used for 
practical and economic reasons. BMI was calculated for all 
subjects, then a Status feature from participant’s BMI was 
generated. Following the World Health Organisation (WHO) 
[52] classification for BMI, 5 standard weight status 
categories associated with BMI ranges for adults were 
derived: Underweight, Normal range, Overweight, Obese 
and Extremely obese. Extremely obese is commonly divided 
into Obese I, Obese II and Obese III, but we grouped then 
into one category for convenience. Participants in this study 
are not distributed evenly in the 5 status levels recognised by 
WHO, representing a data balance issue. The problem of 
data imbalance was solved by creating two classes: Normal 
class and Risk class. The former class includes underweight 
and standard range BMI status, whereas the latter class 
includes the overweight, obese and extremely obese BMI 
status. 57% of participants belonged to Normal class whilst 
the reaming 43% fitted into the Risk class. 
In addition to the genetic profiles, other information such 
as age, gender, height and weight were also collected. The 
BMI and Status variables are described in Table I. All these 
features were taken into consideration for obesity prediction 
processes.  
 
All the risk variants identified are unlikely to be relevant 
for classification purposes. Hence, a subset of the SNPs is 
selected to be relevant to our prediction task. In general, this 
involves the identification of the features that have the 
highest score. Random forest algorithm was used for features 
reduction purposes.  
A set of 13 SNPs was used as features for the 
classification process. The reduced set of features was 
determined by the RF algorithm and a set of 8 SNPs 
recommended in our experimental research as possible 
candidates for the prediction of obesity. These 8 SNPs were 
manually selected after filtering participant’s profiles by 
obesity and T2D related disease-traits SNPs from the 
NHGRI Catalog. Exploratory data analysis was performed to 
identify the SNPs that are potentially associated with the 
BMI status of the participants. The final set of genetic 
variants is composed of 8 SNPs proposed in our research 
experiments: rs12567355, rs3001167, rs586688, rs11241130, 
rs7525133, rs2076529, rs12970134 and rs10195252. While, 
the remaining 5 SNPs were identified by the random forest 
algorithm: rs17104630, rs1447295, rs4242382, rs10090154 
and rs12978500. Table II shows the final set of SNPs and 
related information such as chromosome number where the 
SNP is located, associated reported gene and disease-trait.  
TABLE I 
INFORMATION EXTRACTED FROM THE PGP PROFILES 
Variables Description 
Age Age 
Gender Male = 0, Female = 1 
Height Height in meters 
Weight Weight in Kg 
BMI 
Weight (Kg)
(Height(m))2
 
Status 
Underweight, normal range, Overweight, 
Obese and Extremely obese 
Detailed description of the recorded clinical features 
extracted from the PGP. 
 
 C. Classification Models (Prediction of BMI Status) 
In this study, prediction of obesity is identified by 
discriminating between normal and risk participants. Cross-
validation technique that repeatedly split the data into 
training and test sets is used. 
Machine learning algorithms are designed and evaluated 
using appropriate training and testing sets provided by 3-fold 
Cross Validation resampling and 1 repetition. The data was 
split into three folds. Sensitivity, specificity and area under 
receiver operating characteristics curve are utilized to 
evaluate the different predictive models. The discriminative 
power of the models was measured using AUC. 
Sensitivity (true positives) and Specificity (true 
negatives) values are commonly used to measure the 
predictive capabilities of classifiers. Sensitivities refer to the 
true positive rate or recall rate (Risk class). Specificities 
measure the proportion of true negatives (Normal class). 
Sensitivities are considered higher priority than Specificities, 
in this paper as it is important to predict a risk case so that 
the health specialist can design appropriate therapies.  
The Area Under the Curve (AUC) is an accepted 
performance metric that provides a value equal to the 
probability that a classifier will rank a randomly chosen 
positive instance higher than a randomly chosen negative one 
This is a suitable evaluation method for binary classification. 
Seven well known machine learning algorithms [43], 
[47], [53-54] are used and constructed  as listed in Table III. 
 
IV. RESULTS 
Initial experiments considering the preliminary 6622 
features - 6620 SNPs, plus the age and gender - revealed 
very poor results, practically random. The classifiers were 
unable to discriminate appropriately from the two classes. 
Machine learning models suffer from decrease in 
performance when the number of features is excessively 
high. Consequently, feature selection mechanisms are used 
in order to identify the optimal set of features capable of 
improving the performance of the classifiers. In this section, 
the results obtained when the classifiers are feed with the 
optimal set of features proposed in Table II are presented. 
The results in Table IV show that sensitivities for most of 
the classifiers are lower than the corresponding specificities. 
This means that the majority of the tested models are capable 
of classifying normal cases better than risk ones. However, 
SVM is the only algorithm that shows higher sensitivity than 
specificity. This result is encouraging given that predicting 
risk classes is more important than those that are normal. The 
AUC values are relatively low for GBM and CART with 
slightly higher values for GLMNET, MLP, RF and KNN. 
SVM produced the highest result with marginally over 90 % 
AUC. These results clearly deviate from randomness in 
contrast with the results obtained in previous experiments 
when using all the features without applying feature selection 
techniques. 
 
Even though all the 13 features selected are necessary to 
obtain the best results for SVM, the variable importance 
varied among the various algorithms. The results indicated 
that there is at least a feature or more with no relevance for 
the classifiers. Fig. 1 contains the variable importance for 
each algorithm. Feature rs10195252 was considered not 
relevant in four out of the seven models, including GBM, 
TABLE II 
LIST OF FEATURES SELECTED USING THE RF ALGORITHM 
Feature Chrom 
Reported 
gene/s 
Strongest.SN
P.risk.allele 
Disease-trait 
rs12567355 1 CD53 rs12567355-A Obesity-related traits 
rs3001167 1 EEF1A1P14 rs3001167-G Obesity-related traits 
rs586688 1 NAV1 rs586688-A Obesity-related traits 
rs7525133 1 RHBG rs7525133-A 
Visceral adipose 
tissue adjusted for 
BMI 
rs17104630 6 NKX2-1 rs17104630-G Height 
rs12970134 10 MC4R rs12970134-A 
Type 2 diabetes, 
BMI, Weight, Waist 
circumference 
rs12978500 11 C2CD4C rs12978500-C Obesity-related traits 
rs10195252 12 
COBLL1, 
GRB14 
rs10195252-C 
and -T 
Triglycerides and 
Waist-hip ratio 
rs11241130 18 NREP rs11241130-G Obesity-related traits 
rs2076529 19 BTNL2 rs2076529-C Waist-hip ratio 
rs1447295 21 
MYC, 
intergenic 
rs1447295-A Prostate cancer 
rs4242382 21 intergenic rs4242382-A Prostate cancer 
rs10090154 21 NR rs10090154-T Prostate cancer 
Final set of 13 SNPs (features) selected for the classification 
implementation. SNP associated metadata extracted from the NHGRI 
Catalog is also included. 
TABLE III 
OBJECT CLASSES SELECTED 
Object class Classifier Category 
gbm Stochastic Gradient Boosting. Nonlinear 
glmnet 
Lasso and Elastic-net regularized 
generalized linear models. 
Linear 
rpart 
CART (Classification and Regression 
Trees). 
Nonlinear 
knn K-Nearest Neighbor.
 Nonlinear 
svmRadial 
Radial Basis Function Kernel Support 
Vector Machine. 
Nonlinear 
rf Random Forest. Nonlinear 
nnet Backpropagation Neural Network. Nonlinear 
Methods specified when applying the different classifiers in R. 
TABLE IV 
USING PROPOSED SET OF FEATURES 
Classifier Sensitivity Specificity AUC 
GBM 0.5882 0.7826 0.7366 
GLMNET 0.7059 0.8261 0.8031 
CART 0.6471 0.8696 0.7417 
KNN 0.6471 0.9130 0.8862 
SVM 0.8824 0.8696 0.9054 
RF 0.5294 0.9565 0.8798 
NNET 0.7059 0.8261 0.8517 
Sensitivity, Specificity and AUC values for each classifier when 
predicting the two classes in the test data. 
GLMNET, CART and RF. The features rs4242382 and 
rs1447295 are considered not important in the KNN, SVM 
and MLP architectures. 
Fig. 2 illustrates that GBM and CART performed poorly 
in comparison with the other classifiers. GLMNET 
performed slightly better than GBM and CART. However, 
SVM, KNN, RF and MLP classifiers produced the best 
results in that order, which reflect the sensitivity, specificity 
and AUC values in Table IV. 
V. DISCUSSION 
We present a predictive study using publicly available 
participant’s profiles, as an attempt to understand, and 
effectively identify predisposition to obesity. 
Our study shows the possibility of predicting obesity 
susceptibility based on BMI status from GWAS results, 
using SNPs as features.  
 By performing feature selection using random forest 
algorithm as well as using a set of SNPs recommended from 
our experimental analyses, 13 relevant features are utilised. 
These features were employed as inputs in the selected 
machine learning models. Among the tested models, SVM 
showed the best overall results with SE=88.2%, SP=86.9% 
and AUC=90.5%. Sensitivity analysis indicated that the 
SVM model is robust to the number of selected SNPs. 
As shown in Table II, of the total number of 13 features 
selected, 10 are related to obesity and one to T2D diseases-
traits, whilst the outstanding 3 features, rs1447295, 
rs4242382 and rs10090154 are associated with prostate 
cancer. Some studies suggest that obesity protects against 
localised prostate cancer but increased the risk of advanced 
cancer [55]. 
The feature considered less relevant in 4 of the 
algorithms, rs10195252, is associated with triglycerides and 
waist-hip ratio according to the information extracted from 
the NHGRI Catalog. The features rs4242382 and rs1447295 
 
 
Fig. 2.  ROC curve for PGP data using proposed set of 
features. As the curve moves away from the grey diagonal line 
towards top left corner of the graph, Sensitivity and Specificity 
increase, and at the same time, the area under the graph 
increases. Hence, the models with higher performance will 
show the ROC curve closer to the top left corner, increasing 
the area under curve. 
 
 
 
 
Fig. 1.  Variable importance plots for the seven models. The results 
were obtained with the proposed set of 13 features. Each feature or 
SNP represents how important it was for the algorithm to help in the 
discrimination of the two classes. 
 
are considered not relevant in three models - KNN, SVM and 
MLP - and they are associated with prostate cancer. Results 
also revealed that the features rs2076529 and rs12567355 - 
both associated with obesity related traits -  are in the top 3 
most important features of several models. In the particular 
case of SVM, the top 3 most important variables were 
associated with obesity-related traits - rs12567355 and 
rs3001167 - and waist-hip ratio - rs2076529. Of the three 
features associated with prostate cancer, two of them 
influenced very little the algorithms decisions - rs1447295 
and rs10090154 - and one, rs4242382, did not contributed at 
all. 
VI. CONCLUSION 
Using publicly available data from participants of the 
PGP, this paper presents a genetic profile predictive study. 
Based on previous works and extensive experimental 
research, well documented and publicly available SNPs and 
related metadata are used for subsequent identification of 
risk genetic variants in participant profiles extracted from the 
PGP. Random forest based feature selection algorithm and 
extensive experiments conducted by the authors of this paper 
are used to identify an optimal set of 13 features associated 
with obesity related disease traits and prostate cancer. The 
selected set of features is used to train and test seven well-
known machine learning algorithms. Quality measures 
including sensitivity, specificity and area under receiver 
operating characteristics curve were utilized to evaluate the 
performance of the predictive models. The analyses revealed 
that Support Vector Machine achieved high predictive 
performance among the studied models, followed by K-
Nearest Neighbour.  
Our study produces results deviated from randomness 
and demonstrated the potential of using machine learning 
approaches in the context of the prediction of complex 
diseases and personalized patient care. It should be noted that 
despite the encouraging results reported in this paper, more 
in-depth research is still required. 
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